Neogen Corp. (NEOG)
12.41
-0.60
(-4.61%)
USD |
NASDAQ |
Oct 06, 10:39
Neogen EPS Diluted (Quarterly) : -0.0519 for May 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.0519 |
| February 28, 2026 | -0.0781 |
| November 30, 2025 | -0.0732 |
| August 31, 2025 | 0.1672 |
| May 31, 2025 | -2.821 |
| February 28, 2025 | -0.0505 |
| November 30, 2024 | -2.104 |
| August 31, 2024 | -0.0582 |
| May 31, 2024 | -0.025 |
| February 29, 2024 | -0.0093 |
| November 30, 2023 | -0.0161 |
| August 31, 2023 | 0.0069 |
| May 31, 2023 | 0.0257 |
| February 28, 2023 | 0.0378 |
| November 30, 2022 | -0.1936 |
| August 31, 2022 | 0.0483 |
| May 31, 2022 | 0.1387 |
| February 28, 2022 | 0.0503 |
| November 30, 2021 | 0.1002 |
| August 31, 2021 | 0.158 |
| May 31, 2021 | 0.1459 |
| February 28, 2021 | 0.1246 |
| November 30, 2020 | 0.1487 |
| August 31, 2020 | 0.1488 |
| May 31, 2020 | 0.1539 |
| Date | Value |
|---|---|
| February 29, 2020 | 0.115 |
| November 30, 2019 | 0.1539 |
| August 31, 2019 | 0.1391 |
| May 31, 2019 | 0.1506 |
| February 28, 2019 | 0.1246 |
| November 30, 2018 | 0.1526 |
| August 31, 2018 | 0.145 |
| May 31, 2018 | 0.1673 |
| February 28, 2018 | 0.1588 |
| November 30, 2017 | 0.1234 |
| August 31, 2017 | 0.1162 |
| May 31, 2017 | 0.12 |
| February 28, 2017 | 0.1013 |
| November 30, 2016 | 0.1088 |
| August 31, 2016 | 0.0975 |
| May 31, 2016 | 0.0975 |
| February 29, 2016 | 0.0825 |
| November 30, 2015 | 0.09 |
| August 31, 2015 | 0.0938 |
| May 31, 2015 | 0.0938 |
| February 28, 2015 | 0.075 |
| November 30, 2014 | 0.0788 |
| August 31, 2014 | 0.09 |
| May 31, 2014 | 0.075 |
| February 28, 2014 | 0.0675 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 4.267 |
| QuidelOrtho Corp. | -1.360 |
| Aspira Women's Health, Inc. | -0.0547 |
| VolitionRX Ltd. | -0.8505 |
| Lucid Diagnostics, Inc. | -0.0804 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.30M |
| Revenue (Quarterly) | 225.30M |
| Total Expenses (Quarterly) | 236.60M |
| Enterprise Value | 3.459B |
| Gross Profit Margin (Quarterly) | 37.59% |
| Profit Margin (Quarterly) | -5.02% |
| Earnings Yield | -0.29% |
| Normalized Earnings Yield | -0.1152 |